Viewing Study NCT02495103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:46 PM
Ignite Modification Date: 2026-05-12 @ 11:41 PM
Study NCT ID: NCT02495103
Status: TERMINATED
Last Update Posted: 2021-01-26
First Post: 2015-07-08
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
None Hereditary Leiomyomatosis View
None Renal Cell Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose-Escalation View
None Maximum Tolerated Dose View
None Overall Response View